These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29694611)

  • 1. Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ.
    Chade MC; Piato S; Galvão MAL; Aldrighi JM; Negrini R; Mateus EF; Medeiros EM
    Einstein (Sao Paulo); 2018; 16(1):eAO4065. PubMed ID: 29694611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTF-1 expression in breast carcinoma-the chosen clone matters.
    Bisceglia M; Galliani C; Rosai J
    Am J Surg Pathol; 2011 Jul; 35(7):1087-8. PubMed ID: 21677546
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytologic characteristics of endocrine ductal carcinoma in situ of the breast. A case report.
    Yin H; Schinella R
    Acta Cytol; 2002; 46(5):873-6. PubMed ID: 12365222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
    J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a).
    Kayaselcuk F; Nursal TZ; Polat A; Noyan T; Yildirim S; Tarim A; Seydaoglu G
    J Exp Clin Cancer Res; 2004 Mar; 23(1):105-12. PubMed ID: 15149158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
    Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
    Tsai WC; Chu CH; Yu CP; Sheu LF; Chen A; Chiang H; Jin JS
    Dis Markers; 2008; 24(2):89-99. PubMed ID: 18219094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.
    Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A
    Mod Pathol; 2010 Feb; 23(2):260-9. PubMed ID: 19915523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast.
    Menezes MV; Cestari AL; Almeida O; Alvarenga M; Pinto GA; Gurgel MS; Souza GA; Zeferino LC
    Sao Paulo Med J; 2006 May; 124(3):121-4. PubMed ID: 17119686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
    Ma YH; Wang K; Li L; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasis.
    Li X; Dang X; Sun X
    Eur J Gynaecol Oncol; 2012; 33(2):178-82. PubMed ID: 22611959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma.
    Singh M; Mugler K; Hailoo DW; Burke S; Nemesure B; Torkko K; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):417-23. PubMed ID: 21297444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situ.
    Hwang ES; Lal A; Chen YY; DeVries S; Swain R; Anderson J; Roy R; Waldman FM
    Hum Pathol; 2011 Oct; 42(10):1467-75. PubMed ID: 21496874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP; Cohen C; Hanley KZ; Li XB
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pathological and biological features of symptomatic and mammographically detected ductal carcinoma in situ of the breast.
    Walker RA; Dearing SJ; Brown LA
    Hum Pathol; 1999 Aug; 30(8):943-8. PubMed ID: 10452507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer.
    Wang B; Zhao B; North P; Kong A; Huang J; Miao QR
    PLoS One; 2013; 8(11):e78083. PubMed ID: 24223763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
    Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of bcl-2 expression with clinicopathological features in breast cancer.
    Lee HD; Koo JY; Jung WH
    Yonsei Med J; 1997 Aug; 38(4):206-11. PubMed ID: 9339128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.